Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Single Fraction Stereotactic Radiosurgery Compared with Fractionated Stereotactic Radiosurgery in Treating Patients with Resected Metastatic Brain Disease
- Conditions
- Metastatic Malignant Neoplasm in the Brain
- First Posted Date
- 2019-10-03
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 242
- Registration Number
- NCT04114981
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
πΊπΈBanner MD Anderson Cancer Center, Gilbert, Arizona, United States
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer
- Conditions
- Colorectal Adenocarcinoma
- Interventions
- Dietary Supplement: CholecalciferolOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 455
- Registration Number
- NCT04094688
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈAnchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
πΊπΈAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
- Conditions
- Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid NeoplasmPI3K Gene MutationKRAS G12C MutationNTRK Family Gene MutationCDK Gene MutationROS1 Gene Mutation
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 186
- Registration Number
- NCT03994796
- Locations
- πΊπΈ
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
πΊπΈAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
πΊπΈAlaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Avelumab with or Without Cetuximab in Treating Patients with Advanced Skin Squamous Cell Cancer
- Conditions
- Skin Squamous Cell CarcinomaMetastatic Skin Cancer
- Interventions
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 60
- Registration Number
- NCT03944941
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈAnchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
πΊπΈAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection
- Conditions
- Breast Cancer Stage IIBreast Cancer Stage IBreast Cancer Stage III
- Interventions
- Procedure: Axillary Lymph Node DissectionOther: Quality-of-Life AssessmentProcedure: MappingOther: Questionnaire Administration
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 534
- Registration Number
- NCT03927027
- Locations
- πΊπΈ
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
πΊπΈUC San Diego Moores Cancer Center, La Jolla, California, United States
πΊπΈContra Costa Regional Medical Center, Martinez, California, United States
Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma
- Conditions
- Chronic Lymphocytic LeukemiaPlasma Cell Myeloma
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 521
- Registration Number
- NCT03870633
- Locations
- πΊπΈ
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
πΊπΈAnchorage Oncology Centre, Anchorage, Alaska, United States
πΊπΈKatmai Oncology Group, Anchorage, Alaska, United States
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
- Conditions
- Malignant NeoplasmCarcinomaSurgical Procedure, UnspecifiedHealth Care Provider
- First Posted Date
- 2019-02-28
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 325
- Registration Number
- NCT03857620
- Locations
- πΊπΈ
Helen F Graham Cancer Center, Newark, Delaware, United States
πΊπΈMedStar Washington Hospital Center, Washington, District of Columbia, United States
πΊπΈAugusta University Medical Center, Augusta, Georgia, United States
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
- Conditions
- Malignant Neoplasm
- Interventions
- Other: PlaceboOther: QuestionnaireOther: Quality-of-Life Assessment
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 39
- Registration Number
- NCT03839940
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈKingman Regional Medical Center, Kingman, Arizona, United States
πΊπΈMercy Hospital Fort Smith, Fort Smith, Arkansas, United States
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
- Conditions
- Breast Cancer Stage 0Breast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Stage I
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 627
- Registration Number
- NCT03766009
- Locations
- πΊπΈ
Epic Care-Dublin, Dublin, California, United States
πΊπΈBay Area Breast Surgeons Inc, Emeryville, California, United States
πΊπΈEpic Care Partners in Cancer Care, Emeryville, California, United States
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
- Conditions
- Estrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
- Interventions
- Other: Questionnaire AdministrationOther: Quality-of-Life Assessment
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 93
- Registration Number
- NCT03633331
- Locations
- πΊπΈ
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
πΊπΈAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
πΊπΈAlaska Breast Care and Surgery LLC, Anchorage, Alaska, United States